• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

副炎症在调节干眼疾病进展中的微妙作用。

The Subtle Role of Para-inflammation in Modulating the Progression of Dry Eye Disease.

机构信息

Ocular Surface & ISPRE Ophthalmic, Genoa, Italy.

Ocular Surface and Dry Eye Center, ASST Fatebenefratelli-Sacco, Sacco Hospital - University of Milan, Milan, Italy.

出版信息

Ocul Immunol Inflamm. 2021 May 19;29(4):811-816. doi: 10.1080/09273948.2021.1906908. Epub 2021 May 18.

DOI:10.1080/09273948.2021.1906908
PMID:34003707
Abstract

In patients with DED, the continuous stimuli induced by excessive or persistent cold fiber sensors and overstimulation of nociceptors, as well as tear hyperosmolarity induced by evaporative stress, induce a transitory protective adaptation response called para-inflammation to restore ocular surface homeostasis. This mild subclinical inflammatory status (a type of hormetic response) can become chronic if the stimuli or tissue malfunction is present for a sustained period, causing persistent symptoms and damage to ocular surface epithelia.We review the mechanisms that characterize the transition from para-inflammation to a persistent inflammatory status of the ocular surface, including accumulation of biological waste and damaged/dysfunctional proteins, which, in normal conditions, are eliminated by autophagy, activation of the inflammasomes, and what is currently known about their role in DED pathogenesis. Furthermore, we analyze current treatments that can modulate the inflammatory response of the ocular surface and speculate about new possible therapies to treat para-inflammation.

摘要

在干燥性角结膜炎(DED)患者中,过度或持续的冷纤维传感器刺激以及由蒸发应激引起的泪液高渗,会过度刺激伤害感受器,引发一种短暂的保护性适应反应,称为类炎症反应,以恢复眼表面的稳态。如果刺激物或组织功能障碍持续存在,这种轻度亚临床炎症状态(一种类适应反应)可能会发展为慢性炎症,导致眼表面上皮持续出现症状和损伤。我们回顾了从类炎症反应到眼表面持续炎症状态的转变机制,包括生物废物和受损/功能障碍蛋白的积累,在正常情况下,这些蛋白通过自噬、炎症小体的激活而被清除,目前我们也了解到它们在 DED 发病机制中的作用。此外,我们分析了目前可以调节眼表面炎症反应的治疗方法,并推测了一些新的可能的治疗类炎症的方法。

相似文献

1
The Subtle Role of Para-inflammation in Modulating the Progression of Dry Eye Disease.副炎症在调节干眼疾病进展中的微妙作用。
Ocul Immunol Inflamm. 2021 May 19;29(4):811-816. doi: 10.1080/09273948.2021.1906908. Epub 2021 May 18.
2
Autophagy in dry eye disease: Therapeutic implications of autophagy modulators on the ocular surface.干眼症中的自噬:自噬调节剂对眼表面的治疗意义。
Indian J Ophthalmol. 2023 Apr;71(4):1285-1291. doi: 10.4103/IJO.IJO_2912_22.
3
[A new approach for better comprehension of diseases of the ocular surface].[一种更好理解眼表疾病的新方法]
J Fr Ophtalmol. 2007 Mar;30(3):239-46. doi: 10.1016/s0181-5512(07)89584-2.
4
Corneal autophagy and ocular surface inflammation: A new perspective in dry eye.角膜自噬与眼表炎症:干眼研究的新视角。
Exp Eye Res. 2019 Jul;184:126-134. doi: 10.1016/j.exer.2019.04.023. Epub 2019 Apr 21.
5
Role of hyperosmolarity in the pathogenesis and management of dry eye disease: proceedings of the OCEAN group meeting.高渗性在干眼发病机制和治疗中的作用:OCEAN 会议纪要。
Ocul Surf. 2013 Oct;11(4):246-58. doi: 10.1016/j.jtos.2013.07.003. Epub 2013 Aug 9.
6
Molecular evidence for the role of inflammation in dry eye disease.炎症在干眼病中作用的分子证据。
Clin Exp Optom. 2019 Sep;102(5):446-454. doi: 10.1111/cxo.12849. Epub 2019 Jan 10.
7
Definition and Diagnostic Criteria of Dry Eye Disease: Historical Overview and Future Directions.干眼定义和诊断标准:历史回顾与未来方向。
Invest Ophthalmol Vis Sci. 2018 Nov 1;59(14):DES7-DES12. doi: 10.1167/iovs.17-23475.
8
Hot Topics in Dry Eye Disease.干眼症的热点话题
Curr Pharm Des. 2017;23(4):608-623. doi: 10.2174/1381612822666161208094841.
9
Clinical impact of inflammation in dry eye disease: proceedings of the ODISSEY group meeting.干眼疾病炎症的临床影响:ODISSEY 小组会议记录。
Acta Ophthalmol. 2018 Mar;96(2):111-119. doi: 10.1111/aos.13436. Epub 2017 Apr 8.
10
A mass and solute balance model for tear volume and osmolarity in the normal and the dry eye.正常和干眼的泪液量和渗透压的质量和溶质平衡模型。
Prog Retin Eye Res. 2010 Jan;29(1):59-78. doi: 10.1016/j.preteyeres.2009.11.002. Epub 2009 Nov 26.

引用本文的文献

1
Dry Eye Disease: From Causes to Patient Care and Clinical Collaboration-A Narrative Review.干眼症:从病因到患者护理及临床协作——一篇叙述性综述
Ophthalmol Ther. 2025 May 28. doi: 10.1007/s40123-025-01161-8.
2
Efficacy of topical cyclosporine A in optimizing ocular surface and relieving dry eye symptoms after cataract surgery: a systematic review and meta-analysis of randomized controlled trials.局部应用环孢素A对白内障手术后优化眼表及缓解干眼症状的疗效:一项随机对照试验的系统评价和荟萃分析
Int Ophthalmol. 2025 May 17;45(1):201. doi: 10.1007/s10792-025-03570-x.
3
Dry eye and systemic diseases.
干眼与全身性疾病。
Saudi J Ophthalmol. 2025 Jan 2;39(1):5-13. doi: 10.4103/sjopt.sjopt_182_24. eCollection 2025 Jan-Mar.
4
Parainflammation in the Ocular System: Considerations on the Underlying Mechanisms and Treatment of Dry Eye Disease.眼系统中的副炎症:关于干眼病潜在机制及治疗的思考
Ophthalmol Ther. 2025 May;14(5):883-895. doi: 10.1007/s40123-025-01115-0. Epub 2025 Mar 29.
5
New Eye Drop Formulation Based on Desonide and Xanthan Gum in Dry Eye Disease: Nonclinical Studies.基于地奈德和黄原胶的新型眼药水制剂治疗干眼症的非临床研究
Pharmaceutics. 2025 Feb 12;17(2):235. doi: 10.3390/pharmaceutics17020235.
6
Evaluation of the Performance of an Ocular Surface Modulator Containing ST-Lysyal Versus Hyaluronic Acid Eyedrops in Patients with Dry Eye Disease: A Pilot Study.含ST-赖氨酸的眼表调节剂与透明质酸钠滴眼液治疗干眼疾病的疗效评估:一项初步研究
Ophthalmol Ther. 2025 Jan;14(1):117-128. doi: 10.1007/s40123-024-01062-2. Epub 2024 Nov 19.
7
Dry Eye Para-Inflammation Management: Preclinical and Clinical Evidence on a Novel 0.2% Hyaluronic Acid-Based Tear Substitute with 0.001% Hydrocortisone Sodium Phosphate.干眼炎症管理:关于一种新型含0.001%磷酸氢化可的松的0.2%透明质酸泪液替代品的临床前和临床证据。
J Clin Med. 2024 Sep 23;13(18):5639. doi: 10.3390/jcm13185639.
8
Dry Eye Para-Inflammation Treatment: Evaluation of a Novel Tear Substitute Containing Hyaluronic Acid and Low-Dose Hydrocortisone.干眼炎症治疗:含透明质酸和低剂量氢化可的松的新型泪液替代品评估
Biomedicines. 2023 Dec 11;11(12):3277. doi: 10.3390/biomedicines11123277.
9
Treatment of Dry Eye Disease (DED) in Asia: Strategies for Short Tear Film Breakup Time-Type DED.亚洲干眼症(DED)的治疗:短泪膜破裂时间型干眼症的治疗策略
Pharmaceutics. 2023 Nov 5;15(11):2591. doi: 10.3390/pharmaceutics15112591.
10
Effectiveness of a New Active Tear Substitute Containing 0.2% Hyaluronic Acid and 0.001% Hydrocortisone on Signs and Symptoms of Dry Eye Disease by Means of Low- and High-Tech Assessments.一种含有0.2%透明质酸和0.001%氢化可的松的新型活性泪液替代品通过高科技和低科技评估对干眼病体征和症状的有效性。
Ophthalmol Ther. 2024 Jan;13(1):251-266. doi: 10.1007/s40123-023-00833-7. Epub 2023 Nov 10.